학술논문
PS02.22 Alectinib Following Prior ALK Tyrosine Kinase Inhibitor (TKI) Therapy: Results from the US Expanded Access Program (EAP): Topic: Medical Oncology
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology November 2017 12(11) Supplement 1:S1573-S1573
Subject
Language
ISSN
1556-0864